JPRN-UMIN000008928已完成未知
A randomized phase II trial of Pemetrexed or Pemetrexed plus Carboplatin followed by maintenance Pemetrexed therapy for elderly chemotherapy naive stage IIIB/IV or postoperative recurrence non-squamous non-small cell lung cancer patients - A randomized phase II trial of Pemetrexed or Pemetrexed plus Carboplatin followed by maintenance Pemetrexed therapy for elderly chemotherapy naive stage IIIB/IV or postoperative recurrence non-squamous non-small cell lung cancer patients
Yushima Lung Cancer Oncology Group(YLOG)0 个研究点目标入组 100 人开始时间: 2012年9月19日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Apparent interstitial pneumonia or pulmonary fibrosis detectable on Chest CT 2) Serious complications as follows; 1.Uncontrollable angina pectoris, acute myocardial infarction or congestive heart failue, etc within 1 year 2.Uncontrollable diabetes mellitus and hypertenson 3.Active infectious disease 4. intestinal paralysis or intestinal obstruction 5. Other Serious complications 3) Patiens has pleural effusion, pericardial effusion and ascites to need treatment 4) symptomatic brain metastasis 5) SVC syndrome 6) Active double cancer 7) Pregnancy, breast feeding and suspected or wish of pregnancy 8) Patients who have serious drug hypersensitivity reaction 9) Patients whose participation in the trial is judged to be inappropriate because of psychiatric disease or psychiatric symptoms 10) Patients whose participation in the trial is judged to be inappropriate by the attendeing doctor
研究者
相似试验
进行中（未招募）
不适用
A randomized phase II trial of pemetrexed with or without PF-3512676 for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of one prior chemotherapy regimen for advanced diseaseTreatment of patients with locally advanced or metastatic non-small lung cancer (NSLC) after failure of one prior chemotherapy regimen for advanced diseaseMedDRA version: MedLevel: VTcClassification code 10061873EUCTR2006-001588-52-DEPfizer Pharma GmbH130
已完成
不适用
A randomised phase II study of pemetrexed compared to pemetrexed-carboplatin in pretreated patients with advanced non-small cell lung cancerLung cancerCancerISRCTN38269072VU University Medical Centre (The Netherlands)230
招募中
2 期
A randomized phase II study of pemetrexed versus pemetrexed plus carboplatin in chemotherapy-naive elderly patients with IIIB/IV non-squamous non-small cell lung cancer.JPRN-UMIN000006129Division of Medical Oncology and Molecular Respirology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University60
进行中（未招募）
不适用
Randomized phase II study of pemetrexed versus pemetrexed and carboplatin as second line chemotherapy in advanced non-small-cell lung cancer (NSCLC). - NDPreviously treated patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).MedDRA version: 9.1Level: LLTClassification code 10059515Term: Non-small cell lung cancer metastaticEUCTR2006-004009-24-ITGRUPPO ONCOLOGICO ITALIANO DI RICERCA
进行中（未招募）
不适用
A Randomized Phase 2 Study of Pemetrexed in Combination with Cisplatin or Carboplatin in the First Line Therapy of Advanced NSCLCadvanced NSCLC of Stage IIIb or IV undergoing first line chemotherapyEUCTR2006-002818-35-DEilly Deutschland GmbH